Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
10
×
boston blog main
10
×
boston top stories
life sciences
national blog main
national top stories
clinical trials
san francisco blog main
deals
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
startups
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
glaxosmithkline
medical device
sanofi
alexion pharmaceuticals
autoimmune disorders
avexis
bristol-myers squibb
What
disease
10
×
drug
medicines
new
roundup
adds
bio
cancer
companies
gene
hepatitis
known
liver
nash
news
pharma
pharmaceuticals
potential
proteins
race
research
according
address
advanced
ago
akcea
alliance
allosteric
alnylam’s
alternative
alzheimer's
approval
approved
areas
associated
autoimmune
bad
bff
biosciences
biotech
Language
unset
Current search:
biotech
×
disease
×
" boston blog main "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline